-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HS5UzAD4c491HikjSb62rUm+OXZ2CLcBsdiv92eoTlF3ljJWbhycUhBcy8QFuerx 3ZlsokJ6rN+pC8160wcWkw== 0000950123-99-001050.txt : 19990215 0000950123-99-001050.hdr.sgml : 19990215 ACCESSION NUMBER: 0000950123-99-001050 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: V I TECHNOLOGIES INC CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-55237 FILM NUMBER: 99534563 BUSINESS ADDRESS: STREET 1: 155 DURYEA RD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 5167527314 MAIL ADDRESS: STREET 1: 155 DURYEA RD CITY: MELVILLE STATE: NY ZIP: 11747 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW YORK BLOOD CENTER INC CENTRAL INDEX KEY: 0001079298 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 131949477 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 310 E 67TH STREET CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125703009 MAIL ADDRESS: STREET 1: 310 E 67TH STREET CITY: NEW YORK STATE: NY ZIP: 10021 SC 13G 1 SCHEDULE 13G 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) V.I. Technologies, Inc. ----------------------- (Name of Issuer) Common Stock, $.01 par value ------------------------------ (Title of Class of Securities) 91720100 -------------- (CUSIP Number) February 14, 1999 ------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1 (b) / / Rule 13d-1 (c) /X/ Rule 13d-1 (d) 2 - -------------------------------------------------------------------------------- CUSIP NO. 917920100 PAGE 2 OF 5 PAGES - -------------------------------------------------------------------------------- 13G - -------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) New York Blood Center, Inc. - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 3,434,704 shares NUMBER OF SHARES ----------------------------------------------------- BENEFICIALLY 6. SHARED VOTING POWER none OWNED BY EACH REPORTING ----------------------------------------------------- PERSON WITH 7. SOLE DISPOSITIVE POWER 3,434,704 shares ----------------------------------------------------- 8. SHARED DISPOSITIVE POWER none - ------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,434,704 shares - ------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 27.9% - ------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* CO - ------------------------------------------------------------------------------- 3 PAGE 3 OF 5 PAGES ITEM 1(a). NAME OF ISSUER: V.I. Technologies, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 155 Duryea Road Melville, New York 11747 ITEM 2(a). NAME OF PERSON FILING: New York Blood Center, Inc. ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 310 E. 67th Street New York, New York 10021 ITEM 2(c). CITIZENSHIP: New York ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $.01 par value ITEM 2(e). CUSIP NUMBER: 917920100 4 PAGE 4 OF 5 PAGES ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS: (a) / / A broker or dealer registered under Section 15 of the Exchange Act. (b) / / A bank as defined in Section 3(a)(6) of the Exchange Act. (c) / / An insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) / / An investment company registered under Section 8 of the Investment Company Act. (e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) / / A parent holding company or control person, in accordance with Rule 13d-1(b)(ii)(G). (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) / / A group, in accordance with Rule 13d-1(b)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. / / ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 3,434,704 shares (b) Percent of class: 27.9% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 3,434,704 shares, 5 PAGE 5 OF 5 PAGES (ii) Shared power to vote or to direct the vote none, (iii) Sole power to dispose or to direct the disposition of 3,434,704 shares, (iv) Shared power to dispose or to direct the disposition of none, ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable ITEM 10. CERTIFICATION. Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 1999 ------------------------------------- (Date) /s/ John Wurmser ------------------------------------- (Signature) John Wurmser, Chief Financial Officer ------------------------------------- (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----